Discontinuation report TEVA-OXYBUTYNIN
Report ID | 240078 |
Drug Identification Number | 02230394 |
Brand name | TEVA-OXYBUTYNIN |
Common or Proper name | OXYBUTININ 5mg |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | OXYBUTYNIN CHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-09-06 |
Actual discontinuation date | 2024-09-06 |
Remaining supply date | 2024-09-06 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-10-11 | French | Compare |
v1 | 2024-10-11 | English | Compare |
Showing 1 to 2 of 2